Search the Newsreel

HC Wainwright Has Bearish Forecast for ELTX Q3 Earnings

Nierenberg Investment Management Company LLC Invests $1.09 Billion in Helix Energy Solutions Group, Inc. $HLX

Nierenberg Investment Management Company LLC recently acquired 124,450 shares of Helix Energy Solutions Group, Inc. (HLX) for approximately $1.09 billion, representing a significant portion of its portfolio. This investment positions HLX as Nierenberg's 21st largest holding, with institutional investors collectively owning 91.33% of the …

51,774 Shares in Pembina Pipeline Corp. $PBA Bought by Tacita Capital Inc

Tacita Capital Inc. recently purchased 51,774 shares of Pembina Pipeline Corp. (NYSE:PBA), valued at approximately $2.39 million, making it 1.3% of their portfolio. Institutional investors hold 55.37% of the company, which has a consensus "Moderate Buy" rating and a $64.00 price target. Pembina Pipeline …

Telix Pharmaceuticals (TLX) swings to H1 profit as revenue jumps

Is Helios Towers (LSE:HTWS) gaining traction as connectivity demand keeps expanding?

31,556 Shares in Axcelis Technologies, Inc. $ACLS Bought by Great Lakes Advisors LLC

Great Lakes Advisors LLC has acquired 31,556 shares of Axcelis Technologies (NASDAQ:ACLS) worth approximately $5.98 million during the second quarter, representing about 0.10% of the company. Axcelis Technologies recently reported strong quarterly earnings, beating analyst estimates, and institutional investors collectively own nearly 90% of …

Deutsche Bank AG Invests $111.20 Million in Fidelity National Information Services, Inc. $FIS

Deutsche Bank AG has acquired a new position in Fidelity National Information Services (NYSE:FIS), purchasing over 2.8 million shares valued at approximately $111.20 million. This investment makes Deutsche Bank AG a 0.55% owner of the information technology services provider. The article also details other …

Plains All American: Growth Prospects Strengthening Due To Oil Prices (Rating Upgrade)

Algebris UK Ltd. Takes $41.37 Million Position in Fidelity National Information Services, Inc. $FIS

Algebris UK Ltd. has acquired a new position in Fidelity National Information Services (NYSE:FIS) worth approximately $41.37 million, representing 2.7% of its portfolio. This makes FIS the 16th largest holding for Algebris UK Ltd. Other institutional investors have also adjusted their stakes in FIS, …

Pembina (PBA) Earnings Snapshot: The Available Earnings Metric Delivers a Beat in the Latest Reading; Latest Reaction: Shares Finish 1.70% Lower on the Day - EBITDA Estimate Trend

Pembina (PBA) Results at a Glance: Reported EPS Tops Expectations at the Close; After Results: Shares Fall 1.70% in Latest Trading - Analyst Earnings Estimate

Telix Pharmaceuticals Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TLX) 2026-08-20

Helios (HLIO) Earnings Snapshot: EPS Lands Above Forecast on the Day; Latest Reaction: Shares Move 4.09% Down for the Current Session - Geographic Revenue Trends

Moelis & Co. Class A Actuals & Estimates (NYSE:MC)

This article provides an overview of Moelis & Company (NYSE: MC) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates, revenue, net income, dividends, and other key financial metrics, alongside information on market capitalization and upcoming earnings reports.

Telix Pharmaceuticals (ASX:TLX) Shares Rise Today as H1 Revenue Climbs 22% to US$477 Million

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance1: Double-digit revenue growth and gross …

Investigation launched into EXELIXIS officers for possible self-dealing harming shareholders

Kuehn Law, PLLC has initiated an investigation into whether certain officers and directors of EXELIXIS, Inc. breached their fiduciary duties through potential self-dealing. This probe could result in shareholder damages and calls for corporate governance reforms. Long-term EXEL shareholders are advised to contact the …

Azrieli Group (TASE:AZRG) Stock Faces Debt Strain Behind High Margins

Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?

The battle between Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) has so far been defined by blockbuster injectable weight loss drugs. But the next phase of that rivalry may look very different. Instead of competing over weekly injections, both companies are now racing to …

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases

Research collaboration combines Amplitude's proprietary taRNA with Lilly's global development, manufacturing, and commercialization capabilities Initial programs target infectious diseases with high unmet need, with Lilly retaining options for up to two additional targets BOSTON, Aug. 19, 2026 /PRNewswire/ -- Amplitude Therapeutics, a biotechnology company …

Reliance Worldwide (ASX:RWC) Shares Face Margin Squeeze Under Brookfield Offer

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

Quick Read LLY dominates the GLP-1 race with 48% revenue growth and an unpriced Retratrutide catalyst, while NVO battles 50% Wegovy price cuts and pipeline setbacks. Merck has rallied 31% year to date and now trades near its analyst mean target, making the next …

Helix Energy Solutions Group (HLX), Why Is The Market Taking A Closer Look?

Helix Energy Solutions Group (HLX) is gaining market attention after strong Q2 2026 results, with sales of US$304.02 million and a net income of US$22.72 million, contrasting with a loss a year prior. The stock has seen significant gains, up 8.35% in the past …

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm

Kuehn Law, PLLC is investigating whether certain officers and directors of EXELIXIS, Inc. (NASDAQ: EXEL) breached their fiduciary duties to shareholders, focusing on potential self-dealing. Long-term EXEL stockholders are encouraged to contact the firm for a free consultation to explore potential damages and corporate …

AZRG: NOI and FFO grew modestly, with data center expansion and new contracts driving future growth

Eli Lilly and Co Stock (LLY) Moved Up by 5.18% on Aug 19: What Investors Need To Know

Eli Lilly and Co (LLY) stock rose by 5.18% due to strong quarterly results, increased full-year guidance, and explosive growth in its metabolic franchise with products like Mounjaro and Zepbound. The company's pipeline developments, strategic business execution, and a MACD buy signal are further …

Bridgeline Digital, Inc. - Major Automotive eCommerce Network Deploys HawkSearch AI Across 2.4 Million Product Records

Bridgeline Digital, Inc. announced the successful deployment of its HawkSearch AI platform for a major North American automotive eCommerce network, managing approximately 2.4 million product records. This implementation significantly reduced product indexing time and improved facet response times, marking the first phase of a …

Bluelinx (BXC) Q2 2026 Scorecard: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move: Shares Finish 5.00% Higher for the Current Session - Profit Growth Outlook

Richelieu Hardware (TSX:RCH) Dividend Outlook: Assessing Sustainability Through Cash Flow, Growth and Balance Sheet Strength

EXELIXIS INC : BMO INITIATES COVERAGE WITH MARKET PERFORM RATING; PRICE TARGET $54

BMO has initiated coverage on Exelixis Inc. (EXEL.O) with a "Market Perform" rating. The firm has set a price target of $54 for the biotechnology company. This information was reported by Reuters.

Here's Why You Should Add Reliance Stock to Your Portfolio Now

Reliance, Inc. RS is benefiting from healthy end-market demand and strategic acquisitions that are strengthening its capabilities and broadening its market reach. Strong profitability and cash generation continue to support shareholder returns through share repurchases and dividend growth. We are positive about RS' prospects …

Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play

Quick Read AKTS retains full worldwide rights to its alpha-emitting cancer platform, with $517M cash and binary Q1 2027 trial data looming. NVS, whose Pluvicto grew 43% in Q2 2026, and LLY, already a $60M upfront partner, rank as the top two strategic acquirers. …

Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs. Continue Reading

BMO initiates Exelixis stock at Market Perform, cites patent cliff

BMO Capital initiated coverage on Exelixis (NASDAQ:EXEL) with a Market Perform rating and a $54.00 price target, citing concerns about a patent cliff in early 2030 for its main drug, cabozantinib. While the company's financial health is strong, BMO remains cautious as the follow-up …

JLB & Associates Inc. Acquires Shares of 48,849 Exelixis, Inc. $EXEL

JLB & Associates Inc. has purchased 48,849 shares of Exelixis, Inc. (NASDAQ:EXEL) for approximately $2.66 million, marking a new position in the biotechnology company. Institutional investors and hedge funds collectively own a significant 85.27% of Exelixis, which recently reported strong quarterly earnings exceeding estimates, …

Fidelity (FDBC) Financial Results: The Company Releases Its Current Earnings Data in Latest Trading; Closing Reaction: Shares Finish 1.45% Up in the Latest Session - Capex Guidance